Sectoral Asset Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Sectoral Asset Management’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$836K	Buy	13,285 +2,013	+18%	+$129K	0.58%	45
2026 Q1	$852K	Sell	11,272 -3,468	-24%	-$242K	0.71%	36
2025 Q4	$1.21M	Sell	14,740 -3,665	-20%	-$274K	0.97%	30
2025 Q3	$1.09M	Sell	18,405 -130	-0.7%	-$6.4K	0.68%	48
2025 Q2	$751K	Buy	18,535 +1,285	+7%	+$57.8K	0.5%	53
2025 Q1	$886K	Sell	17,250 -3,050	-15%	-$151K	0.69%	38
2024 Q4	$1.12M	Buy	20,300 +9,000	+80%	+$409K	0.75%	37
2024 Q3	$372K	Buy	+11,300	New	+$318K	0.22%	70

Other funds holding TARS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Sectoral Asset Management's TARS Position: Q2 2026 in Review

Sectoral Asset Management increased its Tarsus Pharmaceuticals (TARS) stake by 18% in Q2 2026, buying an estimated $129K and bringing the position to 13,285 shares worth $836K. The position accounts for 0.58% of the portfolio, ranked #45.

Sectoral Asset Management first reported a position in TARS in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.21M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

Sectoral Asset Management held 13,285 shares of Tarsus Pharmaceuticals worth $836K as of Q2 2026.
Sectoral Asset Management bought 2,013 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $129K.
Tarsus Pharmaceuticals made up 0.58% of Sectoral Asset Management's portfolio in Q2 2026, its #45 holding.
Sectoral Asset Management first reported a position in Tarsus Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
Sectoral Asset Management's Tarsus Pharmaceuticals position peaked at $1.21M in Q4 2025.
257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Sectoral Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.